Showing results (401-410 of 3,370) with videos related to
Sort By:
Pageof 337
Diagnostic Microbiology and Infectious Disease|April 1, 1997
In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococciM A Pfaller, R N JonesArchives of Pathology & Laboratory Medicine|May 1, 1991
Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American PathologistsR N Jones, D C EdsonClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococciL M Deshpande, R N JonesJournal of Clinical Microbiology|May 1, 1992
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar mediumM E Erwin, R N JonesInternational Psychogeriatrics|January 5, 2002
Education bias in the mini-mental state examinationR N Jones, J J GalloThe Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 2, 2000
Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugsM T Lewis, R N JonesDiagnostic Microbiology and Infectious Disease|April 1, 2000
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesA C Gales, R N JonesDiagnostic Microbiology and Infectious Disease|April 15, 2000
Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America)D J Biedenbach, R N JonesThe Journal of Antimicrobial Chemotherapy|November 7, 2000
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas)M A Pfaller, R N JonesDiagnostic Microbiology and Infectious Disease|June 23, 2000
Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999)L M Deshpande, R N JonesPageof 337